Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Immuno-Oncology: Sneak Peek Of Preclinical Candidates Waiting In The Wings

Executive Summary

Which immuno-oncology candidates are poised to begin their first-in-human clinical trials? How many sponsors already have partners or collaborators? What oncology indications have been proposed? And where will these trials take place? Citeline's Rachel L. Meighan-Mantha has the data.


Related Content

Finance Watch: Pandion's $55m Series A Funds Localized Bispecifics For Autoimmune Diseases
Gritstone Grabs $92.7m To Test Personalized Vaccines In Humans
BMS Scoops Cormorant In $520M Immuno-Oncology Deal
Bristol Pushes Pedal To Metal In Immuno-Oncology Combo Testing
Delays As Korea Grapples With Immuno-Oncology Drug Coverage
Immuno-Oncology Attracts Big Deal Dollars For Biotechs
Immuno-Oncology's Next Wave: Key Targets And Emerging Players


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts